V8 Capital Partners

2023年3月16日

自从今年早些时候的Chiarello担任ceo。他以前的创始人、首席执行官和董事长Alveo技术。他还创立了Jetalon解决方案,校准器技术,和猎户座计量,担任斯坦福大学和阿贡国家实验室的研究。Teresia泊斯德,去年10月以来担任临时CEO,将继续与该公司作为一个顾问。泊斯德有超过20年的经验在卫生保健,Celgene公司举行了领导角色,爵士药品,和四方健康在加入54基因。“我们欣赏巨大贡献Teresia使得公司和有强烈热情,经验丰富的领导人帮助使公司向前发展,”珍妮Yip说,董事会主席54基因和辅助的管理合伙人资本。表示:“我们非常信任和信心的愿景和纪律罗恩带给他的升高作用,感谢添加托比的深在非洲的投资经验和专业知识。“Teresia泊斯德托比没问题的,V8 Capital Partners的管理合伙人,一个非洲企业科技风险投资基金总部位于拉各斯,尼日利亚,被任命为54基因的董事会。V8资本成立之前,好的工作的英特尔投资(非洲)和渣打银行(Standard Chartered)在领导角色与私人股本、汇丰和博思艾伦。特米Awogboro, Alcent资本创始合伙人兼联合创始人凯洛天使,和魔法,全球风险投资基金投资组合在非洲,将作为一个顾问和董事会观察员。Awogboro以前Lekki TPG的投资组合公司的执行董事伊美尔医院和地区领先伊美尔医疗基金。 She began her career at Goldman Sachs. “54gene is solving the issue of racial disparity in genomics data and paving the way for more inclusive healthcare outcomes,” said Oke. “With committed investors and partners in Africa and globally, we are solely focused on 54gene’s original mission and building a distinct and unprecedented platform in its diversity and scale.” 54gene aims to significantly improve the inclusion of data from African populations in genomics research. Most genomic data used for development research today is from Europe and North America, while less than 3% is from Africa. Increasing access to genomic data from African populations will improve the effectiveness and relevance of products to the health of African people and power therapeutic discoveries benefiting all populations. The company’s 600,000-sample capacity biobank, which already holds 130,000 samples, is the largest commercial biobank in Africa and one of the most diverse in the world. Through its robust partner and clinical network on the continent, 54gene has access to millions of patients to support its mission. To date, the company has raised $45 million dollars from leading investors including Adjuvant Capital, V8 Capital, KdT Ventures, and Cathay AfricInvest Innovation Fund. You Might Be Interested In